Seeking Alpha
  • Archman Investor
    (JNJ) Rev$15.08Bvs$15.22BDom sales (-)8.1%; inter sales (-)2.6%. cons sales fell 2.7% pharma sales dropped 14.1% No go folks. EPS beat is BS
    10/13/09
    Reply